Search research articles
Contact Us
Filters
Showing results (91-100 of 149) with videos related to
Page
of 15
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 25, 2017
Combined BTK and PI3Kδ Inhibition with Acalabrutinib and ACP-319 Improves Survival and Tumor Control in CLL Mouse Model
Carsten U Niemann, Helena I Mora-Jensen, Eman L Dadashian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2011
Treatment-induced oxidative stress and cellular antioxidant capacity determine response to bortezomib in mantle cell lymphoma
Marc A Weniger, Edgar G Rizzatti, Patricia Pérez-Galán, et al.
Blood
|
December 1, 2020
Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines
Christopher Pleyer, Mir A Ali, Jeffrey I Cohen, et al.
Diagnostic Microbiology and Infectious Disease
|
January 26, 2019
Protracted course of disseminated adenovirus disease with necrotizing granulomas in the liver
Andrea M Lerner, John E Bennett, Stefania Pittaluga, et al.
Journal for Immunotherapy of Cancer
|
November 28, 2022
Patient-derived Siglec-6-targeting antibodies engineered for T-cell recruitment have potential therapeutic utility in chronic lymphocytic leukemia
Matthew G Cyr, Maissa Mhibik, Junpeng Qi, et al.
Leukemia & Lymphoma
|
November 16, 2021
CD5-negative mantle cell lymphoma: clinicopathologic features of an indolent variant that confers a survival advantage
Arshia Soleimani, Alba Navarro, Delong Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 14, 2023
B-cell Receptor Pathway Mutations Are Infrequent in Patients with Chronic Lymphocytic Leukemia on Continuous Ibrutinib Therapy
Jennifer A Woyach, Paolo Ghia, John C Byrd, et al.
Blood
|
May 11, 2018
A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib era
Hannah R Robinson, Junpeng Qi, Erika M Cook, et al.
Blood Advances
|
February 14, 2022
BTK inhibitors impair humoral and cellular responses to recombinant zoster vaccine in CLL
Christopher Pleyer, Kerry J Laing, Mir A Ali, et al.
Blood Advances
|
February 10, 2022
Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphoma
Rahul Lakhotia, Christopher Melani, Kieron Dunleavy, et al.
Page
of 15
Search research articles
Search
Showing results (91-100 of 149) with videos related to
Sort By:
Page
of 15
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 25, 2017
Combined BTK and PI3Kδ Inhibition with Acalabrutinib and ACP-319 Improves Survival and Tumor Control in CLL Mouse Model
Carsten U Niemann, Helena I Mora-Jensen, Eman L Dadashian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2011
Treatment-induced oxidative stress and cellular antioxidant capacity determine response to bortezomib in mantle cell lymphoma
Marc A Weniger, Edgar G Rizzatti, Patricia Pérez-Galán, et al.
Blood
|
December 1, 2020
Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines
Christopher Pleyer, Mir A Ali, Jeffrey I Cohen, et al.
Diagnostic Microbiology and Infectious Disease
|
January 26, 2019
Protracted course of disseminated adenovirus disease with necrotizing granulomas in the liver
Andrea M Lerner, John E Bennett, Stefania Pittaluga, et al.
Journal for Immunotherapy of Cancer
|
November 28, 2022
Patient-derived Siglec-6-targeting antibodies engineered for T-cell recruitment have potential therapeutic utility in chronic lymphocytic leukemia
Matthew G Cyr, Maissa Mhibik, Junpeng Qi, et al.
Leukemia & Lymphoma
|
November 16, 2021
CD5-negative mantle cell lymphoma: clinicopathologic features of an indolent variant that confers a survival advantage
Arshia Soleimani, Alba Navarro, Delong Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 14, 2023
B-cell Receptor Pathway Mutations Are Infrequent in Patients with Chronic Lymphocytic Leukemia on Continuous Ibrutinib Therapy
Jennifer A Woyach, Paolo Ghia, John C Byrd, et al.
Blood
|
May 11, 2018
A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib era
Hannah R Robinson, Junpeng Qi, Erika M Cook, et al.
Blood Advances
|
February 14, 2022
BTK inhibitors impair humoral and cellular responses to recombinant zoster vaccine in CLL
Christopher Pleyer, Kerry J Laing, Mir A Ali, et al.
Blood Advances
|
February 10, 2022
Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphoma
Rahul Lakhotia, Christopher Melani, Kieron Dunleavy, et al.
Page
of 15